378 related articles for article (PubMed ID: 28554215)
21. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?
Ellenbogen KA; Levine JH; Berger RD; Daubert JP; Winters SL; Greenstein E; Shalaby A; Schaechter A; Subacius H; Kadish A;
Circulation; 2006 Feb; 113(6):776-82. PubMed ID: 16461817
[TBL] [Abstract][Full Text] [Related]
22. Predictors of appropriate implantable cardioverter defibrillator (ICD) therapy in primary prevention patients with ischemic and nonischemic cardiomyopathy.
Verma A; Sarak B; Kaplan AJ; Oosthuizen R; Beardsall M; Wulffhart Z; Higenbottam J; Khaykin Y
Pacing Clin Electrophysiol; 2010 Mar; 33(3):320-9. PubMed ID: 19796352
[TBL] [Abstract][Full Text] [Related]
23. Prediction of mortality benefit based on periodic repolarisation dynamics in patients undergoing prophylactic implantation of a defibrillator: a prospective, controlled, multicentre cohort study.
Bauer A; Klemm M; Rizas KD; Hamm W; von Stülpnagel L; Dommasch M; Steger A; Lubinski A; Flevari P; Harden M; Friede T; Kääb S; Merkely B; Sticherling C; Willems R; Huikuri H; Malik M; Schmidt G; Zabel M;
Lancet; 2019 Oct; 394(10206):1344-1351. PubMed ID: 31488371
[TBL] [Abstract][Full Text] [Related]
24. Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis.
Tan VH; Wilton SB; Kuriachan V; Sumner GL; Exner DV
Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):164-70. PubMed ID: 24446023
[TBL] [Abstract][Full Text] [Related]
25. Implantable cardioverter/defibrillators for primary prevention in dilated cardiomyopathy post-DANISH: an updated meta-analysis and systematic review of randomized controlled trials.
Wolff G; Lin Y; Karathanos A; Brockmeyer M; Wolters S; Nowak B; Fürnkranz A; Makimoto H; Kelm M; Schulze V
Clin Res Cardiol; 2017 Jul; 106(7):501-513. PubMed ID: 28213711
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
[TBL] [Abstract][Full Text] [Related]
27. Sudden cardiac death in nonischemic cardiomyopathy: Refining risk assessment.
Zipse MM; Tzou WS
J Cardiovasc Electrophysiol; 2017 Nov; 28(11):1361-1366. PubMed ID: 28670752
[TBL] [Abstract][Full Text] [Related]
28. Indications for ICD and cardiac resynchronization therapy for prevention of sudden cardiac death.
Das M
Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):181-95. PubMed ID: 19210214
[TBL] [Abstract][Full Text] [Related]
29. Implantable cardioverter defibrillators and quality of life: results from the defibrillators in nonischemic cardiomyopathy treatment evaluation study.
Passman R; Subacius H; Ruo B; Schaechter A; Howard A; Sears SF; Kadish A
Arch Intern Med; 2007 Nov; 167(20):2226-32. PubMed ID: 17998496
[TBL] [Abstract][Full Text] [Related]
30. Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis.
Golwala H; Bajaj NS; Arora G; Arora P
Circulation; 2017 Jan; 135(2):201-203. PubMed ID: 27993908
[No Abstract] [Full Text] [Related]
31. The mortality for the implantable cardiac defibrillator in nonischemic cardiomyopathy: An updated systematic review and meta-analysis.
He W; Xue C; Zheng J; Shuai Z
Clin Cardiol; 2022 Dec; 45(12):1163-1170. PubMed ID: 36056632
[TBL] [Abstract][Full Text] [Related]
32. Primary prevention implantable cardioverter-defibrillator and opportunities for sudden cardiac death risk assessment in non-ischaemic cardiomyopathy.
Pathak RK; Sanders P; Deo R
Eur Heart J; 2018 Aug; 39(31):2859-2866. PubMed ID: 30020440
[TBL] [Abstract][Full Text] [Related]
33. An implantable cardioverter-defibrillator for primary prevention in non-ischemic cardiomyopathy: A systematic review and meta-analysis.
Wasiak M; Tajstra M; Kosior D; Gąsior M
Cardiol J; 2023; 30(1):117-124. PubMed ID: 33843044
[TBL] [Abstract][Full Text] [Related]
34. Denervated Myocardium Is Preferentially Associated With Sudden Cardiac Arrest in Ischemic Cardiomyopathy: A Pilot Competing Risks Analysis of Cause-Specific Mortality.
Fallavollita JA; Dare JD; Carter RL; Baldwa S; Canty JM
Circ Cardiovasc Imaging; 2017 Aug; 10(8):. PubMed ID: 28794139
[TBL] [Abstract][Full Text] [Related]
35. Cluster Randomized Trial Examining the Impact of Automated Best Practice Alert on Rates of Implantable Defibrillator Therapy.
Lee J; Szeto L; Pasupula DK; Hussain A; Waheed A; Adhikari S; Sharbaugh M; Thoma F; Althouse AD; Fischer G; Lee JS; Saba S
Circ Cardiovasc Qual Outcomes; 2019 Jun; 12(6):e005024. PubMed ID: 31181957
[TBL] [Abstract][Full Text] [Related]
36. Outcomes After Implantable Cardioverter-Defibrillator Generator Replacement for Primary Prevention of Sudden Cardiac Death.
Madhavan M; Waks JW; Friedman PA; Kramer DB; Buxton AE; Noseworthy PA; Mehta RA; Hodge DO; Higgins AY; Webster TL; Witt CM; Cha YM; Gersh BJ
Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):e003283. PubMed ID: 26921377
[TBL] [Abstract][Full Text] [Related]
37. Positron emission tomography absolute stress myocardial blood flow for risk stratification in nonischemic cardiomyopathy.
Middour TG; Rosenthal TM; Abi-Samra FM; Bernard ML; Khatib S; Polin GM; Rogers PA; Bober RM; Morin DP
J Cardiovasc Electrophysiol; 2020 May; 31(5):1137-1146. PubMed ID: 32064730
[TBL] [Abstract][Full Text] [Related]
38. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
Connolly SJ; Hallstrom AP; Cappato R; Schron EB; Kuck KH; Zipes DP; Greene HL; Boczor S; Domanski M; Follmann D; Gent M; Roberts RS
Eur Heart J; 2000 Dec; 21(24):2071-8. PubMed ID: 11102258
[TBL] [Abstract][Full Text] [Related]
39. Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation.
Gatzoulis KA; Vouliotis AI; Tsiachris D; Salourou M; Archontakis S; Dilaveris P; Gialernios T; Arsenos P; Karystinos G; Sideris S; Kallikazaros I; Stefanadis C
Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):504-12. PubMed ID: 23588627
[TBL] [Abstract][Full Text] [Related]
40. Prognostic Benefit of Cardiac Magnetic Resonance Over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter-Defibrillator Therapy.
Pontone G; Guaricci AI; Andreini D; Solbiati A; Guglielmo M; Mushtaq S; Baggiano A; Beltrama V; Fusini L; Rota C; Segurini C; Conte E; Gripari P; Dello Russo A; Moltrasio M; Tundo F; Lombardi F; Muscogiuri G; Lorenzoni V; Tondo C; Agostoni P; Bartorelli AL; Pepi M
Circ Cardiovasc Imaging; 2016 Oct; 9(10):. PubMed ID: 27729359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
